Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus. 2004

Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
International Centre for Science and High Technology, UNIDO, AREA Science Park, Padriciano 99, I-34012, Trieste, Italy.

We have designed small focused combinatorial library of hexapeptide inhibitors of NS3 serine protease of the hepatitis C virus (HCV) by structure-based molecular design complemented by combinatorial optimisation of the individual residues. Rational residue substitutions were guided by the structure and properties of the binding pockets of the enzyme's active site. The inhibitors were derived from peptides known to inhibit the NS3 serine protease by using unusual amino acids and alpha-ketocysteine or difluoroaminobutyric acid, which are known to bind to the S1 pocket of the catalytic site. Inhibition constants (Ki) of the designed library of inhibitors were predicted from a QSAR model that correlated experimental Ki of known peptidic inhibitors of NS3 with the enthalpies of enzyme-inhibitor interaction computed via molecular mechanics and the solvent effect contribution to the binding affinity derived from the continuum model of solvation. The library of the optimised inhibitors contains promising drug candidates-water-soluble anionic hexapeptides with predicted Ki* in the picomolar range.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
September 2014, Bioorganic & medicinal chemistry letters,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
April 2002, Bioorganic & medicinal chemistry letters,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
February 2006, Journal of medicinal chemistry,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
August 2006, Bioorganic & medicinal chemistry letters,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
November 2008, Recent patents on anti-infective drug discovery,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
October 2016, Current opinion in pharmacology,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
December 2004, Journal of medicinal chemistry,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
September 2003, Antiviral chemistry & chemotherapy,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
April 2002, Biochemistry,
Vladimír Frecer, and Martin Kabelác, and Piergiuseppe De Nardi, and Sabrina Pricl, and Stanislav Miertus
April 1997, The Journal of biological chemistry,
Copied contents to your clipboard!